Recent achievements in developing selective G_q inhibitors.

Area of Science:

• Biochemistry and Pharmacology
• Molecular Biology
• Medicinal Chemistry

Background:

• G proteins are central to G protein-coupled receptor (GPCR) signaling, regulating vital physiological processes.
• Understanding G protein function is hindered by a lack of potent and selective inhibitors.
• The Gq subfamily's role is particularly understudied compared to other GPCR signaling pathways.

Purpose of the Study:

• To review recent advancements in selective Gq inhibitors.
• To highlight chemical syntheses, characterization, and mechanisms of action.
• To underscore the potential of these inhibitors in advancing G protein research and drug discovery.

Main Methods:

• Review of literature on selective Gq inhibitors.
• Analysis of chemical synthesis strategies for natural and synthetic compounds.
• Examination of characterization data and mechanistic studies.

Main Results:

• Identification of natural cyclic depsipeptides (YM-254890, FR900359) and novel inhibitors (GP-2A, BIM-46187) as selective Gq tools.
• Elucidation of recent developments in the synthesis and characterization of these inhibitors.
• Demonstration of their utility in studying Gq-mediated signaling pathways.

Conclusions:

• Selective Gq inhibitors are invaluable pharmacological tools for dissecting GPCR signaling.
• Continued development of these inhibitors will deepen our understanding of G protein structure-function relationships.
• These compounds hold promise for developing therapeutics targeting cancers and other diseases involving G protein dysregulation.